← Leaderboards
Kiarash Emami
Polarean, Inc.
$3,126,706
Attributed
$3,126,706
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999.7K · FY2014–19$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,126,706 · 2
By mechanism
R44$2,978,230 · 1
R43$148,476 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Logistics”
- Jeffrey P Krischer · University Of South Florida$263,628,157
- Melynda Holmes · Technical Resources Inc$232,659,786
- Rashid Settaala · Medical Access Uganda, Ltd$217,159,240
- George Asseng · Dhs-Us Army Medical Research$208,178,288
- Abhik Das · Research Triangle Institute$168,683,434
- Carol Nesel · Westat$157,229,158
Research focus
LogisticsMonitorDesignIonizing RadiationLung ImagingMissionChronic Obstructive Airway DiseaseCystic FibrosisDiagnosisInnovationLungLung DiseasesBiological MarkersMagnetic Resonance ImagingAffectBusinessesAsthmaCostBaseChronic Lung DiseaseChronicDrug DevelopmentClinical TrialsOperation
Grant awards (4)
A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$979,115
R44 · FY2019 · HL · contact PI
A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$999,402
R44 · FY2018 · HL · contact PI
A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease$999,713
R44 · FY2017 · HL · contact PI
Enhanced Optical Module to Enable Polarized 129Xe MRI Use in Clinical Trials$148,476
R43 · FY2014 · HL · contact PI